Our aim was to investigate SETMAR expression in response to treatments, and in correlation with the survival of patients, with the final objective to define whether SETMAR is an interesting prognostic and/or diagnostic marker of GBs. Here, SETMAR is linked to Guillain-Barre syndrome.